Created in 1931 (Germany), Angiolysin own
1125 sister brands
and 17477 competing brands.
The Angiolysin brand is owned by Pfizer Inc, a company listed in New York.
Angiolysin belongs to the Drug Manufacturers business sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.